These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2992498)

  • 1. A novel tumor-associated molecular species of 5'-nucleotide phosphodiesterase.
    Fukazawa H; Suzuki H; Tanaka N
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1072-7. PubMed ID: 2992498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-Nucleotide phosphodiesterase and alkaline phosphatase in tumor cells: evidence for existence of novel species in the cytosol.
    Fukazawa H; Nishimura T; Tanaka N; Suzuki H
    Biochim Biophys Acta; 1988 Jul; 966(1):99-106. PubMed ID: 2839240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic 3',5'-adenosine monophosphate phosphodiesterase in the thymus of normal and leukemic mice.
    Menahan LA; Kemp RG
    J Cyclic Nucleotide Res; 1976; 2(6):417-25. PubMed ID: 190277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the presence of two non-specific nucleotide-sugar-hydrolysing enzymes in rat liver.
    Muilerman HG; Lasthuis AM; Hooghwinkel GJ; Van Dijk W
    Biochem J; 1984 May; 220(1):95-103. PubMed ID: 6331414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleases and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in murine sarcoma virus (Moloney)-infected mice.
    Tsou KC; Lo KW; Herberman RB
    J Natl Cancer Inst; 1978 Oct; 61(4):1077-83. PubMed ID: 212566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle-dependent alterations of the two types of ribonucleases H in L5178y cells.
    Müller WE; Geurtsen W; Zahn RK; Arendes J
    FEBS Lett; 1980 Jan; 110(1):119-22. PubMed ID: 6243584
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of an extracellular matrix-degrading protease derived from a highly metastatic tumor cell line.
    Kramer MD; Robinson P; Vlodavsky I; Barz D; Friberger P; Fuks Z; Schirrmacher V
    Eur J Cancer Clin Oncol; 1985 Mar; 21(3):307-16. PubMed ID: 3891358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cyclic nucleotide phosphodiesterase.
    Appleman MM; Terasaki WL
    Adv Cyclic Nucleotide Res; 1975; 5():153-62. PubMed ID: 165663
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic value of 5'-nucleotide phosphodiesterase isozyme-V for detection of liver metastasis in patients with gastro-intestinal cancer.
    Tomoda H; Furusawa M; Ichino M
    Jpn J Clin Oncol; 1983 Jun; 13(2):353-60. PubMed ID: 6310182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and properties of a mouse liver plasma-membrane glycoprotein hydrolysing nucleotide pyrophosphate and phosphodiester bonds.
    Evans WH; Hood DO; Gurd JW
    Biochem J; 1973 Dec; 135(4):819-26. PubMed ID: 4360250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic distinction between the TK+ and TK- chromosomes in the L5178Y TK+/- 3.7.2C mouse-lymphoma cell line.
    Hozier J; Sawyer J; Clive D; Moore M
    Mutat Res; 1982 Dec; 105(6):451-6. PubMed ID: 7155165
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of horse and fetal calf serum on the expression of tumor-associated antigen and tumorigenicity of L5178Y leukemia/lymphoma cells.
    Rabinovsky ED; Yang TJ
    Leuk Res; 1986; 10(11):1331-40. PubMed ID: 3796035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkaline phosphodiesterase-active antigens in plasma membranes of rat liver.
    Blomberg F; Berzins K
    Biochim Biophys Acta; 1980 May; 598(2):305-13. PubMed ID: 6155145
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased activity of low-Km cyclic adenosine 3':5'-monophosphate phosphodiesterase in plasma membranes of Morris hepatoma 5123tc (h).
    Hickie RA; Walker CM; Datta A
    Cancer Res; 1975 Mar; 35(3):601-5. PubMed ID: 163686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulators of the metabolism of L-asparagine: a search for endogenous inhibitors.
    Cooney DA; Jones MT; Milman HA; Young DM; Jayaram HN
    Int J Biochem; 1980; 11(6):519-39. PubMed ID: 6103827
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of hydroxyurea treatment on lysosomal membrane stability and enzyme latency in L5178Y cells in culture.
    Przybyszewski WM; Czartoryska B; Malec J
    Neoplasma; 1986; 33(1):27-31. PubMed ID: 3960209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel phosphodiesterase I from the soluble fraction of erythrocytes.
    Haugen HF
    Biochim Biophys Acta; 1981 Jun; 659(2):411-21. PubMed ID: 6266489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I phosphodiesterase in the isolated, brush-border membrane of Hymenolepis diminuta.
    Gamble HR; Pappas PW
    J Parasitol; 1981 Oct; 67(5):617-22. PubMed ID: 6271942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkaline phosphodiesterase I release from eucaryotic plasma membranes by phosphatidylinositol-specific phospholipase C. I. The release from rat organs.
    Nakabayashi T; Ikezawa H
    J Biochem; 1986 Mar; 99(3):703-12. PubMed ID: 3011761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribonuclease and phosphodiesterase activities in rat hepatocyte plasma membranes.
    Gavard D; Gagnon C; De Lamirande G
    Biochim Biophys Acta; 1974 Dec; 374(2):207-19. PubMed ID: 4373079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.